Elsevier

Process Biochemistry

Volume 121, October 2022, Pages 514-528
Process Biochemistry

Exploring the industrial importance of a miracle herb Withania somnifera (L.) Dunal: Authentication through chemical profiling, in vitro studies and computational analyses

https://doi.org/10.1016/j.procbio.2022.07.028Get rights and content

Highlights

  • This study unveils metabolic profile and biological activities of Withania somnifera.

  • The Chloroform (WS-C) fraction showed high phenolic contents and bioactivities.

  • UHPLC-MS analysis of WS-C fraction leads to identify 100 secondary metabolites.

  • Docking studies validated the enzyme inhibition activities of the extract.

  • Multivariate statistical analysis established relationship between phenolics and bioactivities.

Abstract

Withania somnifera (L.) Dunal has been identified as a miracle herb, thus the present study was carried out to investigate W. somnifera growing in Cholistan Desert for its secondary metabolic profile and various biological activities. The WS-C fraction of methanolic extract (WS-M) of W. somnifera was found rich in phenolics (39.96 ± 0.90 mg GAE/g extract), and it exhibited significant DPPH (30.69 ± 0.78 mg TE/g extract) and ABTS (113.60 ± 2.41 mg TE/g extract) free radical inhibitory activities, cupric (Cu+2) and ferric (Fe+3) reducing potential as 157.51 ± 2.10 and 124.60 ± 0.34 mg TE/g extract. The same fraction also exhibited strong total antioxidant capacity (1.39 ± 0.01 mmol TE/g extract) in phosphomolybdenum assay. Other fractions displayed relatively lower potential. In metal-chelating assay, WS-M, WS-E and WS-B showed nearly equal potential with values of 22.35 ± 0.62, 20.96 ± 0.12 and 22.10 ± 0.75 mg EDTAE/g of the extract, while in AChE, BChE and tyrosinase inhibitory assay, again WS-C fraction was most active (7.50 ± 0.21, 8.01 ± 0.53 mg GALAE/g extract and 36.81 ± 0.20 mg KAE/g extract, respectively). In α-amylase and α-glucosidase inhibitory assay, WS-C showed significant potential with values as 0.74 ± 0.01 and 1.14 ± 0.004 mmol ACAE/g extract, respectively. UHPLC-MS analysis of WS-C fraction leads to identify 100 secondary metabolites of phenolic, withanolide, terpenoid, steroid, lignin, flavonoid and limonoid classes of compounds. This profile makes W. somnifera a fascinating plant. These findings were validated by computational studies, which revealed that selected compounds exhibited high binding free energy and inhibition constants with the enzymes tested. Pearson correlation analysis clearly established that the phenols in the tested extracts were the main players as antioxidants and enzyme inhibitors, which was also substantiated through Principal Component Analysis (PCA). These results suggest that chloroform might be suitable for preparing further applications with W. somnifera extracts, and this plant can be placed in the list of top-selling herbs, and may become source of commercial assets.

Introduction

Withania somnifera (L.) Dunal (Family: Solanaceae) has been listed among the top-rated medicinal plants. World Health Organization (WHO) has also recognized this plant as a precious medicinal herb [1]. National Medicinal Plant Board of India has listed W. somnifera among top 32 prime herbs due to its huge demand [2]. It is an important component of folk medicinal system being used as natural healer. People have used W. somnifera for thousands of years to relieve stress, increase energy level, and improve concentration [3], [4]. It is also a well-known herb in Pakistan, Africa and Middle East, where it is known as Ashwagandha or Asgandh; it is also called as Indian ginseng or winter cherry [5].

Powdered root extract has been reported to treat various health conditions like anxiety, fertility issues, inflammation, fatigue, pain, skin diseases, diabetes, arthritis and epilepsy or as a general tonic to increase energy and to decrease ageing process [6]. In addition to above conditions, it also improves sleep quality and bipolar disorder [7], [8], [9], [10], [11], [12]. It is further reported to boost the immune system, increase the production of vital fluids, lymph blood, semen, cells, memory power and possesses immunomodulatory, hemopoietic, rejuvenation and antineoplastic effects [13]. W. somnifera enhances human physical performance, including strength and oxygen use during exercise [14], [15], [16]. The food supplements comprising extracts of this plant have been shown to increase male fertility by increasing testosterone level, sperm concentration, semen volume, and sperm motility [17], [18]. Extract of W. somnifera has also been reported to reduce inflammatory effects in COVID-19 patients when given as an Ayurvedic drug [19]. Another striking feature of this plant is that it exhibits chemo-preventive effects [20]. Visweswari and other research groups have identified wide range of secondary metabolic classes through chemical testing that includes phenols, flavonoids, tannins, saponins, alkaloids, steroids, terpenoids, glycosides and reducing sugar, which they held responsible for anti-inflammatory, anti-spasmodic, anti-analgesic, neuroprotective and diuretic effects of this plant [21], [22]. Anil Bhatia and co-workers analyzed fruit extract of W. somnifera through GC-MS and NMR, and have reported 82 compounds of fatty acid, aliphatic and aromatic amino acid, polyol, sugar, sterol, tocopherol, phenolic acid and withanamides classes of secondary metabolites [23]. In another analytical study through LC-MS/MS, 32 withanamides, 22 withanolides, 3 steroidal saponins, 2 lignanamides, feruloyl tyramine, methoxy feruloyl tyramine and a diglucoside of hydroxyl palmitic acid were identified [24]. Alam and his co-workers have studied methanolic extracts of various parts of W. somnifera for its antioxidant and antibacterial bioactivities [25]. In Pakistan, W. somnifera is popular with name of Asgandh as an evergreen bush growing widely along the road sides and in fields. However, despite of its importance in folk medicine system, it is still an ignored herb in Pakistan, and has not got the status of cultivated plant on commercial grounds. The above literature revealed that this plant is intensively investigated in several capacities, however, it is known fact that environmental changes lead to change in metabolic profile of a plant species. Therefore, the aim of the present study was to offer a deep insight in to the chemical and pharmaceutical properties of W. somnifera growing in Cholistan Desert of Pakistan. For this purpose, various extracts of W. somnifera were investigated for their bioactive contents, complete metabolic picture and several in vitro and computational analyses. Most of these studies have been carried out first the time for this top-rated herb.

Section snippets

Collection of the plant material, extraction and fractionation

The aerial parts of W. somnifera were collected from Cholistan Desert at latitude of 28° 49′ 59.99′ N and longitude of 71° 39′ 59.99′ E, in district Bahawalpur, Punjab, Pakistan, during the plant's peak growing period i.e. first week of March 2021. The plant was identified by the plant taxonomist Dr. Zaheer Abbas, University of Education Lahore. A voucher specimen number WS-ZA-2021 has been deposited in the herbarium. The plant material was dried under shade for 20 days. A total of 2 Kg of the

Results and discussion

Methanolic extract (WS-M) of W. somnifera was divided into chloroform (WS-C), ethyl acetate (WS-E) and n-butanol (WS-B) soluble fractions, which were subjected to various studies for metabolic profiling and biological activities.

Conclusion

The present study led to conclude that W. somnifera growing in Cholistan Desert of Pakistan is rich in variety of secondary metabolites, mostly of phenolic, withanolide and limonoid classes of small organic compounds. Its extracts possess potential antioxidant properties, especially in ABTS free radical scavenging, metal reducing and metal-chelating assays, which generally could be attributed to its phenolic compounds. However, in literature, a steroidal lactone, withaferin A (WA) has been

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References (90)

  • K. Dastmalchi et al.

    Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract

    LWT-Food Sci. Technol.

    (2008)
  • Y. Nicolet et al.

    Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products

    J. Biol. Chem.

    (2003)
  • Y.P. Ng et al.

    Plant alkaloids as drug leads for Alzheimer's disease

    Neurochem. Int.

    (2015)
  • H.J. Jung et al.

    In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives

    Comp. Struct. Biotechnol. J.

    (2019)
  • S. Lordan et al.

    The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts

    Food Chem.

    (2013)
  • J. Gorelick et al.

    Hypoglycemic activity of withanolides and elicitated Withania somnifera

    Phytochemistry

    (2015)
  • S. Bhargavi et al.

    Shankar, Dual herbal combination of Withania somnifera and five Rasayana herbs: A phytochemical, antioxidant, and chemometric profiling

    J. Ayurveda Integr. Med

    (2021)
  • K. Kaur et al.

    In vitro shoot multiplication using meta-Topolin and leaf-based regeneration of a withaferin A rich accession of Withania somnifera (L.) Dunal

    Ind. Crop. Prod.

    (2021)
  • K. Kaur et al.

    Development of robust in vitro culture protocol for the propagation of genetically and phytochemically stable plants of Withania somnifera (L.) Dunal (Ashwagandha), Ind. Crop

    Prod

    (2021)
  • S. Paul et al.

    Withania somnifera (L.) Dunal (Ashwagandha): a comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects

    Biomed. Pharmacother.

    (2021)
  • A. Arias et al.

    Exploring the potential of antioxidants from fruits and vegetables and strategies for their recovery

    Innov. Food Sci. Emerg. Technol.

    (2022)
  • N. Shen et al.

    Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity

    Food Chem.

    (2022)
  • T. Wang et al.

    Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweeds

    Food Chem.

    (2009)
  • C. Rice-Evans et al.

    Antioxidant properties of phenolic compounds

    Trends Plant Sci.

    (1997)
  • H.S. Arruda et al.

    Recent advances and possibilities for the use of plant phenolic compounds to manage ageing-related diseases

    J. Funct. Foods

    (2020)
  • P. Mishra et al.

    Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)

    Bioorg. Med. Chem.

    (2019)
  • P.K. Mukherjee et al.

    Validation of medicinal herbs for anti-tyrosinase potential

    J. Herb. Med

    (2018)
  • K. Papoutsis et al.

    Fruit, vegetables, and mushrooms for the preparation of extracts with α-amylase and α-glucosidase inhibition properties: a review

    Food Chem.

    (2021)
  • Y. Tan et al.

    Digestive enzyme inhibition activity of the phenolic substances in selected fruits, vegetables and tea as compared to black legumes

    J. Funct. Foods

    (2017)
  • R. Taqui et al.

    Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer’s disease

    Phytomed

    (2022)
  • M.H. Mirjalili et al.

    Steroidal lactones from Withania somnifera, an ancient plant for novel medicine

    Molecules

    (2009)
  • N.D. Prajapati et al.

    A handbook of medicinal plants: a complete source book

    A Handb. Med. Plant.: A Complet. Source Book

    (2003)
  • E. Logie et al.

    Berghe, Tackling chronic inflammation with withanolide phytochemicals—a withaferin A perspective

    Antioxidants

    (2020)
  • P. Singh et al.

    Addressing challenges to enhance the bioactives of Withania somnifera through organ, tissue, and cell culture based approaches

    BioMed. Res. Int.

    (2017)
  • L. Ashwagandha, Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and...
  • K.R. Chengappa et al.

    Randomized placebo-controlled adjunctive study of an extract of Withania somnifera

    Cogn. Dysfunct. Bipolar Disord., J. Clin. Psych.

    (2013)
  • J. Salve et al.

    Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study

    Cureus

    (2019)
  • A.L. Lopresti et al.

    An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study

    Medicine

    (2019)
  • A.B. Speers et al.

    Effects of Withania somnifera (Ashwagandha) on stress and the stress-related neuropsychiatric disorders anxiety, depression, and insomnia

    Curr. Neuropharmacol.

    (2021)
  • M.A. Pratte et al.

    An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)

    J. Alt. Complement. Med.

    (2014)
  • J.M. Gannon et al.

    Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial

    Ann. Clin. Psychiatry

    (2019)
  • S. Bhasin et al.

    Review on bioactive metabolites of Withania somnifera.(L) Dunal and its pharmacological significance

    J. Pharm. Phytochem

    (2019)
  • D.A. Bonilla et al.

    Effects of Ashwagandha (Withania somnifera) on physical performance: systematic review and bayesian meta-analysis

    J. Funct. Morphol. Kinesiol

    (2021)
  • J. Pérez-Gómez et al.

    Effects of Ashwagandha (Withania somnifera) on VO2max: a systematic review and meta-analysis

    Nutrients

    (2020)
  • S. Wankhede et al.

    Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial

    J. Int. Soc. Sports Nutr.

    (2015)
  • Cited by (6)

    • In vitro and in silico bioactivities and chemical profiling of Nepeta leucolaena to validate its use in nutraceutical or biopharmaceutical applications

      2023, Process Biochemistry
      Citation Excerpt :

      The results were calculated as millimoles (mM) of acarbose equivalents per gram of the dry extract (mm ACAE/g extract) [11]. The α-glucosidase inhibition assay was performed as reported previously [12,13]. The glutathione (0.5 mg/mL, 50 µL), PNPG (10 mM, 50 µL) and α-glucosidase solution (0.2 u/mL, 50 mL) in phosphate buffer (pH 6.8) were mixed and incubated for 15 min at 37 °C.

    • In vitro antioxidant and enzyme inhibitory studies, computational analysis and chemodiversity of an emergency food plant Caralluma edulis (Edgew.) Benth. ex Hook.f: A multifunctional approach to provide new ingredients for nutraceuticals and functional foods

      2022, Food Bioscience
      Citation Excerpt :

      100 g of the Ce-M was suspended in distilled water (500 mL) and extracted with n-hexane and ethyl acetate to get 25 g of hexane (Ce-H) and 22 g of ethyl acetate (Ce-E) soluble fractions, respectively, whereas aqueous layer (Ce-W) was dried up to 45 g of the residue. The total phenolic contents (TPC) were measured by Folin-Ciocalteu protocol, while total flavonoid contents (TFC) were estimated in aluminum chloride assays (Slinkard and Singleton, 1977; Tousif et al., 2022) In these analyses, flavonoid and phenolic contents are expressed as rutin (mg RE/g extract) and gallic acid (mg GAEs/g extract) equivalents respectively. Already established protocols (Grochowski et al., 2017) were followed to estimate antioxidant activity of the extracts.

    View full text